Sitemap
- Top diplomats of S. Korea, US hold phone talks on GSOMIA, defense cost sharing
- Esper calls on S. Korea, Japan to show leadership to resolve dispute
- '전쟁포기' 선언한 일본서 무기전시회 열린 이유
- 박항서 감독 '발끈'하게 한 태국 코치, AFC에 제소당해(종합)
- [Weekender] Taiwan arrives on Korean cafe scene
- [Weekender] Vietnamese coffee and sandwiches in Seoul
- [Travel Bits] Festivals and sights across Korea
- [Box Office] Movies in theaters this week
- [Eye Plus] Tracing footsteps of beloved author Kim Yu-jeong
- [Weekender] A culinary journey to Asian neighbors
- Train services reduced as strike continues for 3rd day
- Topping box office upon release, 'Frozen 2' to continue winning streak
- [Weekender] Malaysian chef cooks ‘agak agak’ in Yeonnam-dong
- Jeju Air opens routes to Phu Quoc, Bohol
- Prosecutors raid Coast Guard in Sewol probe
- USFDA approves SK Biopharmaceuticals’ new anti-epileptic drug
- Korea to enhance protection of foreign wives from violence
- Korean EV battery makers' market share sharply up in Sept.
- Moon emboldened by new corporate investment in chip material production
- Woori Bank resolves ‘overhang’ issue by divesting holdings share
- Warmbier's parents urge Seoul to pressure Pyongyang on human rights issues
- Grammys under fire after BTS wasn't nominated for 2020 event
- The New Grandeur gains a bold, younger and sportier look
- Investors lose trust in financial firms amid derivative fiasco: survey
- Cheong Wa Dae to announce GSOMIA decision at 6 pm, termination plan apparently averted
- KBO club SK Wyverns to post LHP Kim Kwang-hyun
- [Newsmaker] Ex-vice minister mired in orgy scandal cleared of all charges
- Hideous criminals to be banned from marrying foreign women
- Seoul holds off on ending GSOMIA
- Football legend Cha receives German order of merit
- Senior NK official says US should take responsibility if chance of diplomacy disappears
- Groundwork laid for negotiation on Tokyo’s trade curbs, GSOMIA: Kang
- Ruling, main opposition parties welcome gov't's decision to postpone GSOMIA termination
- Bridge Biotherapeutics to become first ‘NRDO’ biotech to go public in Korea